Branding for Financial & Legal Advisors
Are you looking to secure business where the money is in life sciences? Sanofi’s $1.9B deal with Dren Bio is just the most recent of a string of cell engager deals that have involved AbbVie, AstraZeneca, J&J, Ipsen, Amgen, Merck, Roche-Genentech, GSK and Novartis.
This is your platform to engage with decision-makers assessing cell engagers as the next hot drug modality to dominate biotech and pharma deal-making. Don’t miss out on your chance to accelerate first-in-class & best-in-class immune cell engagers from the pre-competitive preclinical stage to clinic & market as the next wave of hotly anticipated deals take shape.
This meeting convenes C-suite executives and business development leaders from pioneering biotech and pharma. Therefore, partners, managing directors, and senior advisors leverage this exclusive summit to connect, gain insights, and influence key industry developments.
Establish your credibility and commitment in this dynamic life science sector by aligning your expertise with the market's most promising opportunities and enhancing your ability to deliver targeted, value-driven advice on deal-making, strategy, and partnership execution.
We offer key opportunities to elevate your presence, including a dedicated 30-minute presentation slot. Alternatively, consider becoming a founding or hosting partner - a role that strategically positions you as a central connector for essential industry contacts and a key driver of successful deals in the dynamic autoimmunity and inflammation space.
William Hobson-Corbett
Business Development Manager
Contact: sponsor@hansonwade.com